Liver neoplasms are tumors or cancers that start in the liver. These are growths in the liver tissue that can be cancerous or non-cancerous. Doctors need to check these growths to understand what they are and how to treat them.
Every report comes from a Lived member, sent anonymously.
Have you tried Hepatectomy for Liver Tumors?
Liver tumors are abnormal growths in the liver, the large organ under the right ribs that processes nutrients, makes the proteins blood needs to clot and clears alcohol, medicines and other wastes from the blood. The term covers very different things. Some tumors are benign (not cancer): they can grow, but they do not invade nearby tissue or spread. Others are cancers that start in the liver, called primary liver cancer. In the United States, though, cancer found in the liver more often started somewhere else, such as the colon, pancreas, breast or lung, and spread there. That is secondary, or metastatic, liver cancer, and it is treated as the original cancer. The most common benign growth is a hemangioma, a cluster of small blood vessels that rarely causes symptoms and is often found by chance on a scan done for another reason. Focal nodular hyperplasia and hepatic adenoma are other benign growths. Among adults, most primary liver cancers are hepatocellular carcinoma (HCC), which starts in the liver's main cells; a smaller share starts in the small bile ducts inside the liver (intrahepatic cholangiocarcinoma). Children can develop a different liver cancer, hepatoblastoma, which is treated differently. Liver cancer often causes no symptoms until it is advanced, which is one reason it can be hard to treat. When symptoms appear, people may notice a lump or ache under the right ribs, pain near the right shoulder blade, a swollen belly, yellowing of the skin and whites of the eyes (jaundice), feeling full after a small meal, or weight loss without trying.
Benign and cancerous liver tumors have different causes. Most hepatocellular carcinoma develops in a liver that has been damaged for years. Long-lasting hepatitis B or hepatitis C infection and cirrhosis, the heavy scarring that replaces healthy liver tissue after long-term injury, are the main drivers. Heavy alcohol use and fatty liver disease linked to excess weight and type 2 diabetes can both lead to cirrhosis, and liver cancer occasionally develops in these conditions even before cirrhosis. Smoking, aflatoxin (a mold toxin that can contaminate poorly stored corn and nuts, mainly outside the US) and some inherited conditions, such as untreated hemochromatosis (iron overload), add to the risk. Men develop HCC more often than women, and risk climbs when several factors combine. Some of this risk can be lowered. Hepatitis B vaccination, treatment of chronic hepatitis B or C, and addressing heavy drinking and metabolic health all help prevent the liver damage that cancer grows from. Even so, many people with risk factors never develop liver cancer, and some people develop it with no known risk factor. Benign tumors follow different patterns. Hepatic adenomas are more common in women and are linked to birth control pills and to anabolic steroid use. Hemangiomas and focal nodular hyperplasia usually have no identifiable cause.
Liver tumors are usually found in one of two ways: by chance on an ultrasound, computed tomography (CT) scan or magnetic resonance imaging (MRI) scan done for something else, or through regular checks in people known to be at high risk. Early liver cancer rarely causes symptoms and is hard to feel beneath the ribs, so people with cirrhosis of any cause, and some people with chronic hepatitis B even without cirrhosis, are advised to have a liver ultrasound with an alpha-fetoprotein (AFP) blood test every six months. Checking this way makes it more likely that cancer is caught at a stage where cure is possible, although it can still miss some tumors. There is no routine screening for people at average risk. AFP is a protein that many liver cancers release into the blood. A rising level is a clue, not a diagnosis: AFP can be normal even when cancer is present, and it can be raised by hepatitis, cirrhosis, pregnancy and some other cancers. When a spot is found, the next step is usually a CT or MRI with contrast dye, with pictures taken at several moments as the dye flows through the liver. Liver cancer often has a recognizable pattern on these scans, so a biopsy is not always needed. A biopsy, in which a thin needle removes a small sample to examine under a microscope, is used when imaging leaves doubt or the exact tumor type matters. Blood tests of liver function show how well the liver is working, which shapes treatment choices as much as the tumor itself. If cancer is confirmed, staging describes how large it is, whether it has spread within or beyond the liver, how well the liver is working and how the person is managing day to day. A widely used system, the Barcelona Clinic Liver Cancer (BCLC) system, runs from very early (stage 0) to end stage (stage D) and links each stage to likely treatment options.
Treatment depends on what kind of tumor it is, its size and number, whether it has spread, and how healthy the rest of the liver is. Most benign tumors need no treatment. Hemangiomas and focal nodular hyperplasia are usually just noted, and sometimes rechecked, unless they cause symptoms or the diagnosis is uncertain. Hepatic adenomas are handled more carefully because some can bleed and a small number turn into cancer. Doctors often advise removing them, and stopping birth control pills or anabolic steroids can make some adenomas shrink. For hepatocellular carcinoma found early, the aim is cure. Surgery removes the part of the liver containing the tumor, and the remaining liver can regrow, but it suits only people whose remaining liver is healthy enough to take over; advanced cirrhosis can rule it out. A liver transplant replaces the whole liver, treating both the cancer and the diseased liver around it, for selected people whose cancer has not spread beyond the liver and who can receive a donor liver. For small tumors, ablation destroys the tumor through a needle using heat (radiofrequency or microwave energy), freezing or alcohol, without open surgery. Precisely aimed radiation, such as stereotactic body radiation therapy, is another option for some tumors. When the cancer is larger or there are several tumors but none outside the liver, embolization can help. A thin tube is threaded through an artery to the vessel feeding the tumor, which is then blocked, often together with a chemotherapy drug (chemoembolization). This aims to control growth rather than cure. For cancer that cannot be removed or has spread, medicines that work throughout the body are used. Options include immunotherapy combinations that help the immune system attack the cancer, such as atezolizumab (Tecentriq) given with bevacizumab (Avastin), a drug that blocks the blood vessels tumors rely on, or durvalumab (Imfinzi) given with tremelimumab (Imjudo). Targeted pills such as lenvatinib (Lenvima) are another first option, and further drugs are available if the cancer grows. These treatments aim to slow the cancer and help people live longer. Immunotherapy can also make the immune system inflame healthy organs, such as the bowel, lungs, liver or thyroid, which is why blood tests and symptom checks continue throughout treatment. Cancer that spread to the liver from elsewhere is treated according to where it started, although surgery or ablation of liver spots is sometimes part of that plan. Clinical trials, and supportive care focused on symptoms and quality of life, are worth discussing at any stage.
What happens next depends mostly on which kind of tumor it is. A hemangioma or focal nodular hyperplasia usually changes nothing about daily life. A hepatic adenoma may mean follow-up scans or planned surgery. For primary liver cancer, the outlook depends heavily on how early it is found and how well the liver works. In US data for people diagnosed between 2014 and 2020, about 37% of people whose cancer had not spread beyond the liver were alive five years later, compared with 13% when it had reached nearby structures or lymph nodes and 3% when it had spread to distant organs. People with small tumors that can be removed, especially without cirrhosis, tend to do considerably better, and about 60% to 70% of people with early cancer who receive a transplant are alive at five years. These figures are averages from people treated years ago, before some current treatments, and cannot predict any one person's course. Living with liver cancer usually also means living with the liver disease underneath it. Many people manage hepatitis treatment, cirrhosis care and cancer care at the same time, often with a team that may include a liver specialist, a cancer specialist (oncologist), a surgeon and an interventional radiologist, who performs ablation and embolization. Treatment can bring tiredness, appetite changes and time away from work and routines. Even after treatment aimed at cure, the cancer can come back in the liver or elsewhere, so regular scans and blood tests continue. Treating hepatitis and avoiding heavy drinking help protect the liver that remains.
See a doctor if you notice yellowing of the skin or eyes, a lump or persistent ache under the right ribs, a swelling belly, feeling full after small meals, or weight loss you cannot explain. These are more often caused by something other than cancer, but they need checking. If you have cirrhosis or chronic hepatitis B, ask whether you should have ultrasound checks every six months, and keep those appointments even when you feel well. During immunotherapy, contact your care team promptly about new diarrhea, a new cough or shortness of breath, or a new rash, since early treatment of immune side effects matters. Sudden, severe belly pain, especially with lightheadedness or fainting, can mean a liver tumor is bleeding. Call 911.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Liver Tumors is like, what's helped you, or ask the community a question.